PGC vs REGN · P/E 18, rev $228.1M vs P/E 14, rev $14.34B
Peapack-Gladstone Financial (PGC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Peapack-Gladstone Financial (PGC) is a banks - regional company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PGC revenue for 2024-12-31 was $228.1M. Net income was $33.0M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. PGC currently screens at market cap $778.9M and trailing P/E 17.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PGC currently screens at market cap $778.9M and trailing P/E 17.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PGC and REGN stock pages for the full models.
Not investment advice.